{"id":"W4309827972","doi":"10.1001/jamaoncol.2022.5486","title":"Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Ipilimumab; Pembrolizumab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Oncology; Randomized controlled trial; Randomization; Clinical trial; Adjuvant therapy; Cancer; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796151,0.0001578501,0.001032722,0.0002506546,0.00004844826,0.000002725024,0.0001605936,0.0001183942,0.0002475966],"category_scores_gemma":[0.0003889676,0.0001101947,0.0001248702,0.000316687,0.0001343668,0.00004982237,0.00009710444,0.0002272555,5.785569e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006720874,"about_ca_system_score_gemma":0.0006294203,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001074916,"about_ca_topic_score_gemma":0.0004685927,"domain_scores_codex":[0.9977738,0.0007829145,0.0006419367,0.0002775064,0.0002821451,0.0002416725],"domain_scores_gemma":[0.9976636,0.001433886,0.0003736596,0.0002977886,0.0001773948,0.00005373392],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6178963,0.001864783,0.3641977,0.0006978253,0.0003920752,0.0000106665,0.0004862874,0.00001193971,0.004656131,0.00008729198,0.0001387289,0.009560276],"study_design_scores_gemma":[0.08601483,0.03795896,0.872549,0.0001183721,0.00005852976,0.000004684658,0.0003086365,0.00001368799,0.001759559,0.00003007495,0.001067255,0.0001163993],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971039,0.0001051292,0.00003419381,0.0005106014,0.0003661091,0.001593762,0.0001685571,0.00001821336,0.00009947971],"genre_scores_gemma":[0.9988213,0.000008475603,0.0001887643,0.0002803529,0.00001925987,0.0004022778,0.0001403545,0.00002647694,0.0001127598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5318815,"threshold_uncertainty_score":0.449361,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02678739375407324,"score_gpt":0.33753905426309,"score_spread":0.3107516605090168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}